| Product NDC: | 61570-081 |
| Proprietary Name: | Tussigon |
| Non Proprietary Name: | hydrocodone bitartrate and homatropine methylbromide |
| Active Ingredient(s): | 1.5; 5 mg/1; mg/1 & nbsp; hydrocodone bitartrate and homatropine methylbromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61570-081 |
| Labeler Name: | Monarch Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088508 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19850730 |
| Package NDC: | 61570-081-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (61570-081-01) |
| NDC Code | 61570-081-01 |
| Proprietary Name | Tussigon |
| Package Description | 100 TABLET in 1 BOTTLE (61570-081-01) |
| Product NDC | 61570-081 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hydrocodone bitartrate and homatropine methylbromide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19850730 |
| Marketing Category Name | ANDA |
| Labeler Name | Monarch Pharmaceuticals, Inc. |
| Substance Name | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
| Strength Number | 1.5; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |